© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Menopause
Medical cannabis popular among patients with menopause-related symptoms
August 30, 2022
More women are using medical cannabis for menopause-related symptoms, according to research recently published in Menopause.
Short menstrual cycles may predict earlier menopause, worse symptoms in midlife
August 24, 2022
Women with shorter menstrual cycles may reach menopause earlier and experience more severe symptoms overall, according to research in Menopause.
Fezolinetant making waves for VMS
July 26, 2022
Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).
New hormone therapy guidelines from the North American Menopause Society
July 22, 2022
The 2022 position statement confirms hormone therapy as the most effective treatment for vasomotor symptoms in menopause and includes updated guidelines for age- and condition-specific treatment plans.
Hormone shift in menopause contributes to cardiovascular risk in aging women
May 18, 2022
New research from a team of investigators in Europe suggests hormonal changes during menopause could explain up to 10% of the increase in LDL-C associated with the transition to menopause among aging women
Topical interventions on the vaginal microbiota in postmenopausal women
April 28, 2022
Vaginal estradiol tablets produced significant changes in vaginal microbiota and metabolome with a lowering pH, especially in women with highly divers bacterial communities at baseline, according to a secondary analysis in JAMA Network Open.
Rotating shift work and onset of menopause
April 28, 2022
A Canadian study published in the journal Menopause found a significant link between rotating shift work and delayed onset of menopause.
Endometriosis and early natural menopause
April 13, 2022
Women with laparoscopically confirmed endometriosis are at significantly higher risk for early natural menopause (ENM), and this risk was greater for nulliparous women and women who never reported using oral contraceptives, according to a study in JAMA Network Open.
Anti-mullerian hormone premenopause can predict bone loss risk later in life
April 08, 2022
New research from the University of California Los Angeles (UCLA) suggests assessments of anti-Mullerian hormone levels could help clinicians predict or detect bone loss among premenopausal women.
Does bilateral oophorectomy impact dementia rates?
March 28, 2022
Bilateral oophorectomy is associated with an increased risk of dementia, according to findings from a prospective cohort study in the journal Menopause.